Cardinal Health lifts 2024 profit view on demand for costly specialty drugs [Reuters]
Cardinal Health, Inc. (CAH)
Last cardinal health, inc. earnings: 2/6 06:55 am
Check Earnings Report
US:NYSE Investor Relations:
ir.cardinalhealth.com/home
Company Research
Source: Reuters
unit selling costly specialty drugs used to treat complex conditions such as cancer. Drug distributors, including rival , have been benefiting from growing sales of specialty medicines at a time when prices of generic, or copycat, versions have been falling due to intense competition. Cardinal now expects 2024 adjusted earnings in the range of $7.30 to $7.40 per share, compared with $7.20 to $7.35 per share forecast previously. According to LSEG data, analysts were expecting an annual profit of $7.28 per share. The company also announced its preliminary outlook for 2025 adjusted profit, expecting at least $7.50 per share, compared with estimates of $7.87. Cardinal sources a substantial amount of its revenue from the pharmaceutical and specialty solutions unit through which it distributes branded and generic drugs, specialty medicines and over-the-counter healthcare and consumer products. The unit generated revenues of $50.7 billion, up 9% year-over-year, in the third quarter e
Show less
Read more
Impact Snapshot
Event Time:
CAH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CAH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CAH alerts
High impacting Cardinal Health, Inc. news events
Weekly update
A roundup of the hottest topics
CAH
News
- Cardinal Health, Inc. (NYSE: CAH) had its price target lowered by analysts at Argus from $120.00 to $115.00. They now have a "buy" rating on the stock.MarketBeat
- IntelliGuard Appoints Seasoned Leader as New Chief Product Officer for Enhanced Healthcare Solutions [Yahoo! Finance]Yahoo! Finance
- Surgical Drapes Market Report 2024: Analysis and Forecast 2018-2033 Featuring Cardinal Health, Thermo Fisher Scientific, 3M Company, Medline Industries, and Ecolab [Yahoo! Finance]Yahoo! Finance
- Cardinal Health (NYSE:CAH) Is Increasing Its Dividend To $0.5056 [Yahoo! Finance]Yahoo! Finance
- Global Healthcare Distribution Strategic Industry Report 2024-2030: Substandard and Counterfeit Drugs, an Urgent Challenge in the Supply Chain that Needs to be Addressed [Yahoo! Finance]Yahoo! Finance
CAH
Earnings
- 5/2/24 - Beat
CAH
Sec Filings
- 5/2/24 - Form 10-Q
- 5/2/24 - Form 8-K
- 4/23/24 - Form 8-K
- CAH's page on the SEC website